申请人:Eli Lilly and Company Limited
公开号:US05929072A1
公开(公告)日:1999-07-27
A pharmaceutical compound having the formula: ##STR1## in which n is 1 or 2, m is 1 or 2, p is 1 to 6, q is 0 or 1 to 3, R.sup.1 and R.sup.2 are each hydrogen or C.sub.1-4 alkyl, R.sup.3, R.sup.4 and R.sup.5 are each hydrogen, C.sub.1-4 alkyl, optionally substituted phenyl or optionally substituted phenyl-C.sub.1-4 alkyl, or R.sup.3 and R.sup.4 together form an alkylene link of formula --(CH.sub.2).sub.3 -- or --(CH.sub.2).sub.4 --, or R.sup.4 and R.sup.5 together with the carbon atom to which they are attached form a C.sub.3-6 cycloalkyl group, R.sup.6 is C.sub.1-4 alkyl, C.sub.1-4 alkoxy, carboxy, hydroxy, cyano, halo, trifluoromethyl, nitro or amino, the dotted line represents an optional double bond, and the fluorine atom is attached at the 6 or 7-position; and salts and esters thereof.
一种具有以下式子的药物化合物:##STR1##
其中n为1或2,m为1或2,p为1到6,q为0或1到3,R.sup.1和R.sup.2分别为氢或C.sub.1-4烷基,R.sup.3,R.sup.4和R.sup.5分别为氢,C.sub.1-4烷基,可选取代苯基或可选取代苯基-C.sub.1-4烷基,或R.sup.3和R.sup.4一起形成式子--(CH.sub.2).sub.3--或--(CH.sub.2).sub.4--的烷基链,或R.sup.4和R.sup.5与它们连接的碳原子一起形成C.sub.3-6环烷基,R.sup.6为C.sub.1-4烷基,C.sub.1-4烷氧基,羧基,羟基,氰基,卤素,三氟甲基,硝基或氨基,虚线表示可选的双键,氟原子附着在6或7位;以及其盐和酯。